{"id":51311,"date":"2023-09-20T09:20:11","date_gmt":"2023-09-20T09:20:11","guid":{"rendered":"https:\/\/medsname.com\/lotepred-eye-drop\/"},"modified":"2026-04-30T10:25:29","modified_gmt":"2026-04-30T10:25:29","slug":"lotepred-eye-drop","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/lotepred-eye-drop\/","title":{"rendered":"Lotepred Eye Drop"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div class=\"medsbase-tldr-answer\" style=\"background:#fffbe6;border-left:4px solid #f5a623;padding:14px 18px;margin:14px 0 22px;border-radius:6px;font-size:15px;line-height:1.55;\">\n<h3 style=\"margin:0 0 6px;font-size:17px;color:#8a6d3b;\">\u26a1 R\u0103spuns rapid \u2014 Ce este Lotepred Eye Drop?<\/h3>\n<p style=\"margin:0;\">Lotepred Eye Drop este Loteprednol etabonat 0,5%, un corticosteroid topic \u201esoft\u201d (conceput pentru un risc mai mic de cre\u0219tere a PIO) pentru inflama\u021bii oculare \u2014 uveit\u0103, inflama\u021bie postoperatorie, conjunctivit\u0103 alergic\u0103 \u0219i exacerb\u0103ri ale sindromului ochiului uscat. Se utilizeaz\u0103 de 2\u20138 ori pe zi, \u00een func\u021bie de severitate. Monitoriza\u021bi PIO dac\u0103 este utilizat mai mult de 2 s\u0103pt\u0103m\u00e2ni.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f6f7fb;border:1px solid #e3e5ee;border-radius:8px;padding:14px 18px;margin:18px 0;font-size:14px;line-height:1.55;\"><strong style=\"color:#1f3661;\">De ce s\u0103 comanzi de la MedsBase?<\/strong> Produs de un produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 <a href=\"\/ro\/reviews\/\" rel=\"noopener\">Peste 1.400 de recenzii verificate ale clien\u021bilor<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Lotepred Eye Drop este procurat de la un produc\u0103tor certificat WHO-GMP \u0219i expediat \u00een \u00eentreaga lume \u00een ambalaj simplu \u0219i discret. Fiecare comand\u0103 este acoperit\u0103 de <a href=\"\/ro\/medsbase-re-shipment-assurance-policy\/\" rel=\"noopener\">Politica noastr\u0103 de Reexpediere Garantat\u0103<\/a> \u2014 dac\u0103 nu a sosit \u00een 20 de zile lucr\u0103toare, expediem din nou f\u0103r\u0103 costuri suplimentare. Sus\u021binut de peste 1.400 de recenzii verificate.<\/p>\n<h2>Ce este Lotepred Eye Drop?<\/h2>\n<p>Lotepred Eye Drop este fabricat de Sun Pharma \u0219i con\u021bine Loteprednol etabonat 0,5% sub form\u0103 de solu\u021bie oftalmic\u0103 steril\u0103 sau suspensie. Loteprednol etabonatul este un steroid \u2018soft\u2019 \u2014 conceput s\u0103 fie metabolizat rapid \u00een metaboli\u021bi inactivi \u00een ochi, av\u00e2nd cel mai mic risc de cre\u0219tere a PIO dintre to\u021bi steroizii topici. Preferat pentru inflama\u021bii cronice \u0219i utilizare postoperatorie.<\/p>\n<h2>Cum func\u021bioneaz\u0103<\/h2>\n<p>Loteprednol etabonatul se leag\u0103 de receptorii intracelulari de glucocorticoidi, suprind\u00e2nd transcrip\u021bia citokinelor pro-inflamatorii, chemokinelor \u0219i moleculelor de adeziune leucocitar\u0103. Rezultatul este reducerea ro\u0219e\u021bii, umfl\u0103turii, durerii \u0219i infiltra\u021biei celulelor imune.<\/p>\n<h2>Indica\u021bii<\/h2>\n<ul>\n<li><strong>Uveit\u0103 anterioar\u0103 (iritis, iridociclitis\u0103)<\/strong><\/li>\n<li><strong>Inflama\u021bie postoperatorie<\/strong> dup\u0103 opera\u021bia de cataract\u0103, glaucom, cornee sau refractiv\u0103<\/li>\n<li><strong>Conjunctivit\u0103 alergic\u0103 sever\u0103<\/strong> \u2014 c\u00e2nd antihistaminicele \u0219i stabilizatorii de celule mastocitare sunt ineficien\u021bi<\/li>\n<li><strong>Cheratoconjunctivita vernal\u0103<\/strong><\/li>\n<li><strong>Exacerb\u0103ri ale ochiului uscat<\/strong> \u2014 administrare pe termen scurt de steroid de poten\u021b\u0103 sc\u0103zut\u0103 concomitent cu ini\u021bierea ciclosporinei<\/li>\n<li><strong>Episclerit\u0103, sclerit\u0103<\/strong> (\u00een cadrul specializat)<\/li>\n<li><strong>Respingere de grefon corneal<\/strong> (specializat)<\/li>\n<\/ul>\n<h2>Doza<\/h2>\n<p>Foarte variabil \u00een func\u021bie de indica\u021bie \u0219i severitate. Intervale tipice:<\/p>\n<ul>\n<li>Uveit\u0103 sever\u0103: 1\u20132 pic\u0103turi la fiecare 1\u20132 ore \u00een timpul zilei, cu reducere treptat\u0103 pe s\u0103pt\u0103m\u00e2ni<\/li>\n<li>Post-cataract\u0103: QID timp de 1 s\u0103pt\u0103m\u00e2n\u0103, TID s\u0103pt\u0103m\u00e2na 2, BID s\u0103pt\u0103m\u00e2na 3, OD s\u0103pt\u0103m\u00e2na 4<\/li>\n<li>Puseu alergic \/ puseu de ochi uscat: de 4 ori pe zi timp de 2\u20134 s\u0103pt\u0103m\u00e2ni<\/li>\n<\/ul>\n<p>Urma\u021bi \u00eentotdeauna programul specific de reducere progresiv\u0103 stabilit de oftalmolog. \u00centreruperea brusc\u0103 dup\u0103 utilizare \u00eendelungat\u0103 poate provoca inflama\u021bie de rebound.<\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:12px 16px;margin:14px 0;border-radius:4px;font-size:14px;line-height:1.55;\"><strong style=\"color:#a94442;\">R\u0103spuns la steroizi \u2014 cre\u0219tere a PIO.<\/strong> Aproximativ 30% dintre pacien\u021bi sunt \u201cresponderi la steroizi\u201d \u0219i dezvolt\u0103 PIO crescut\u0103 la utilizarea de steroizi topici, ap\u0103r\u00e2nd de obicei dup\u0103 2+ s\u0103pt\u0103m\u00e2ni de terapie. Netratat\u0103, aceasta poate provoca leziuni permanente ale nervului optic glaucomatoase. <strong>Verifica\u021bi PIO la 2 s\u0103pt\u0103m\u00e2ni \u0219i din nou la 4\u20136 s\u0103pt\u0103m\u00e2ni pentru orice tratament mai lung de 2 s\u0103pt\u0103m\u00e2ni.<\/strong> Riscul este cel mai mare cu prednisolonul, cel mai mic cu loteprednolul.<\/div>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:12px 16px;margin:14px 0;border-radius:4px;font-size:14px;line-height:1.55;\"><strong style=\"color:#a94442;\">Alte riscuri pe termen lung ale steroizilor.<\/strong> <strong>Cataract\u0103 subcapsular\u0103 posterioar\u0103<\/strong> se dezvolt\u0103 la utilizarea cronic\u0103 \u2014 ireversibil\u0103. <strong>Reactivarea cheratitei herpetice simplex<\/strong> poate provoca ulcer\u0103ri dendritice care pun \u00een pericol vederea. <strong>Infec\u021bie secundar\u0103<\/strong> din cauza imunosupresiei. Confirma\u021bi \u00eentotdeauna c\u0103 diagnoza este neinfec\u021bioas\u0103 \u00eenainte de a \u00eencepe; nu utiliza\u021bi niciodat\u0103 peste o leziune corneal\u0103 herpetic\u0103 sau fungic\u0103.<\/div>\n<h2>Efecte Secundare<\/h2>\n<p><strong>Local:<\/strong> arsur\u0103 la instilare, vedere \u00eence\u021bo\u0219at\u0103 (mai ales cu suspensii \u2014 agita\u021bi bine), PIO crescut\u0103 (r\u0103spuns la steroizi), cataract\u0103 subcapsular\u0103 posterioar\u0103 la utilizare cronic\u0103, infec\u021bie ocular\u0103 secundar\u0103 (bacterian\u0103, viral\u0103, fungic\u0103), vindecare \u00eent\u00e2rziat\u0103 a r\u0103nilor, midriaz\u0103, ptoz\u0103 (rar).<\/p>\n<p><strong>Sistemic (rar la administrare topic\u0103):<\/strong> Tr\u0103s\u0103turi cushingoide, suprresie a axei HPA \u2014 extrem de rar\u0103 doar de la pic\u0103turi oculare.<\/p>\n<h2>Avertismente &amp; Contraindica\u021bii<\/h2>\n<ul>\n<li>Cheratit\u0103 herpetic\u0103 activ\u0103 \u2014 contraindicat absolut<\/li>\n<li>Cheratit\u0103 fungic\u0103 activ\u0103 \u2014 contraindicat absolut<\/li>\n<li>Cheratit\u0103 vaccinial\u0103, varicelar\u0103, micobacterian\u0103 \u2014 contraindicat absolut<\/li>\n<li>Infec\u021bie bacterian\u0103 netratat\u0103 (f\u0103r\u0103 acoperire antibiotic\u0103) \u2014 contraindicat relativ<\/li>\n<li>Istoric de glaucom \u2014 risc crescut de IOP; preferabil loteprednol<\/li>\n<li>Copii \u2014 monitorizare atent\u0103; risc crescut de cataract\u0103<\/li>\n<li>Sarcin\u0103\/al\u0103ptare \u2014 discuta\u021bi; absorb\u021bie topic\u0103 minim\u0103<\/li>\n<li>Pur\u0103tori de lentile de contact \u2014 scoate\u021bi lentilele \u00een timpul tratamentului<\/li>\n<\/ul>\n<h2>Depozitare<\/h2>\n<p>P\u0103stra\u021bi la 15\u201325\u00b0C, protejat de lumin\u0103. Agita\u021bi bine \u00eenainte de fiecare utilizare dac\u0103 este etichetat ca suspensie. Arunca\u021bi dup\u0103 28 de zile de la prima deschidere.<\/p>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3>C\u00e2nd este Lotepred Eye Drop alegerea potrivit\u0103?<\/h3>\n<p>C\u00e2nd este necesar\u0103 utilizare cronic\u0103 sau repetat\u0103 \u0219i riscul de cre\u0219tere a PIO trebuie minimizat \u2014 exacerb\u0103ri ale sindromului ochiului uscat, alergie recurent\u0103, reducere progresiv\u0103 postoperatorie prelungit\u0103, pacien\u021bi cu antecedente de r\u0103spuns la steroizi.<\/p>\n<h3>Ce este r\u0103spunsul la steroizi?<\/h3>\n<p>Predispozi\u021bie genetic\u0103 de a dezvolta IOP crescut la utilizarea steroizilor topici. Aproximativ 1\/3 din popula\u021bie. Debutul apare de obicei dup\u0103 2+ s\u0103pt\u0103m\u00e2ni. Verifica\u021bi IOP dac\u0103 utiliza\u021bi orice steroid topic pentru mai mult de 2 s\u0103pt\u0103m\u00e2ni.<\/p>\n<h3>C\u00e2t timp pot folosi Lotepred Eye Drop?<\/h3>\n<p>Tratamente acute: 2\u20134 s\u0103pt\u0103m\u00e2ni cu reducere treptat\u0103. Utilizarea cronic\u0103 necesit\u0103 supraveghere oftalmologic\u0103 cu verific\u0103ri regulate ale IOP \u0219i ale cristalinului. Loteprednolul este preferat pentru orice tratament care dep\u0103\u0219e\u0219te 4 s\u0103pt\u0103m\u00e2ni.<\/p>\n<h3>De ce trebuie s\u0103 evit pic\u0103turile oculare Lotepred pentru herpes?<\/h3>\n<p>Keratitisul cu herpes simplex poate distruge corneea c\u00e2nd se adaug\u0103 steroizi f\u0103r\u0103 acoperire antiviral\u0103. Ulcerul dendritic se poate extinde \u00een ulcer geografic, boal\u0103 stromal\u0103 sau cheratit\u0103 endotelial\u0103 \u2014 duc\u00e2nd la pierdere permanent\u0103 a vederii. Confirma\u021bi \u00eentotdeauna cauza \u00eenainte de \u00eenceperea tratamentului.<\/p>\n<h3>Pot pic\u0103turile oculare Lotepred provoca cataract\u0103?<\/h3>\n<p>Da \u2014 utilizarea cronic\u0103 provoac\u0103 cataract\u0103 subcapsular\u0103 posterioar\u0103, \u00een special la copii \u0219i dup\u0103 luni sau ani de terapie continu\u0103. Limita\u021bi durata; trece\u021bi la loteprednol sau AINS acolo unde este posibil.<\/p>\n<h3>Sunt pic\u0103turile oculare Lotepred sigure \u00een timpul sarcinii?<\/h3>\n<p>Absorb\u021bia topic\u0103 este minim\u0103. \u00cen general acceptabil atunci c\u00e2nd este clar indicat. Discuta\u021bi cu medicul prescriptor.<\/p>\n<h3>\u0218i despre lentilele de contact?<\/h3>\n<p>\u00centrerupe\u021bi utilizarea lentilelor \u00een timpul tratamentului \u2014 conservan\u021bii \u0219i imunosupresia indus\u0103 de steroizi cresc riscul de cheratit\u0103 microbial\u0103.<\/p>\n<h3>Ce se \u00eent\u00e2mpl\u0103 dac\u0103 vederea mea se \u00eenr\u0103ut\u0103\u021be\u0219te \u00een timpul tratamentului?<\/h3>\n<p>Consult oftalmologic \u00een aceea\u0219i zi. Posibilit\u0103\u021bi: boal\u0103 herpetic\u0103 neglijat\u0103, infec\u021bie fungic\u0103, cre\u0219tere a presiunii intraoculare (IOP) cauzat\u0103 de steroizi sau complica\u021bie corneean\u0103.<\/p>\n<h3>Care este diferen\u021ba dintre prednisolon, fluorometolon \u0219i loteprednol?<\/h3>\n<p>Acetat de prednisolon: cel mai potent, cel mai mare risc de cre\u0219tere a IOP. Fluorometolon: poten\u021b\u0103 medie, risc mai mic de cre\u0219tere a IOP. Loteprednol: steroid \u2018bl\u00e2nd\u2019 metabolizat rapid \u00een ochi, cel mai mic risc de cre\u0219tere a IOP \u2014 preferat pentru utilizare cronic\u0103. Toate necesit\u0103 monitorizare dup\u0103 2 s\u0103pt\u0103m\u00e2ni.<\/p>\n<h3>Pot \u00eentrerupe brusc tratamentul cu pic\u0103turi oculare Lotepred?<\/h3>\n<p>Nu \u2014 \u00eentreruperea brusc\u0103 poate provoca inflama\u021bie de rebound. Urma\u021bi \u00eentotdeauna programul de reducere progresiv\u0103 prescris.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3>Alte medicamente pentru \u00eengrijirea ochilor<\/h3>\n<p>Clien\u021bii care vizualizeaz\u0103 acest produs iau \u00een considerare \u0219i aceste alternative din gama noastr\u0103 <a href=\"\/ro\/eye-care\/\">\u00cengrijirea ochilor<\/a> de:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/pred-forte-eye-drops\/\">Pred Forte (acetat de prednisolon)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/fml-eye-drop\/\">FML Eye Drop (fluorometolon)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/lotepred-eye-drop\/\">Lotepred Eye Drop (loteprednol)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/acular-ls-drop\/\">Acular LS (ketorolac)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/megabrom-eye-drop\/\">Megabrom (bromfenac)<\/a><\/li>\n<\/ul>\n<h3>Declinare de responsabilitate medical\u0103<\/h3>\n<p style=\"font-size:13px;color:#555;\">Informa\u021biile de pe aceast\u0103 pagin\u0103 au scop educa\u021bional \u0219i nu \u00eenlocuiesc sfatul medical al unui oftalmolog sau optometrist calificat. Afec\u021biunile oculare pot amenin\u021ba rapid vederea \u2014 pierderea brusc\u0103 a vederii, durerea intens\u0103 sau trauma reprezint\u0103 urgen\u021be oftalmologice. Consulta\u021bi \u00eentotdeauna un specialist \u00een \u00eengrijirea ochilor \u00eenainte de a \u00eencepe, \u00eentrerupe sau modifica orice tratament.<\/p>","protected":false},"excerpt":{"rendered":"<p>Lotepred (loteprednol etabonat 0,5%) \u2014 colir cu steroid u\u0219or cu cel mai mic risc de cre\u0219tere a PIO. Inflama\u021bie postoperatorie, exacerbare de ochi uscat, conjunctivit\u0103 alergic\u0103. Agita\u021bi bine.<\/p>","protected":false},"featured_media":51312,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3343,3342],"product_tag":[],"class_list":{"0":"post-51311","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-eye-care","8":"product_cat-general-health","10":"first","11":"outofstock","12":"shipping-taxable","13":"purchasable","14":"product-type-variable","15":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/51311","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=51311"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/51312"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=51311"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=51311"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=51311"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=51311"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}